Federated Hermes, Inc. Leap Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

  • $43.6 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$1.49 - $2.37 $730 - $1,161
-490 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
$1.68 - $2.17 $220 - $284
-131 Reduced 21.1%
490 $1,000
Q2 2020

Aug 13, 2020
BUY
$1.39 - $2.84 $512 - $1,047
369 Added 146.43%
621 $1,000
Q1 2020

May 13, 2020
BUY
$1.06 - $2.94 $267 - $740
252 New
252 $1,000

Others Institutions Holding LPTX

# of Institutions
1
Shares Held
265K
Call Options Held
0
Put Options Held
0
View Full List

About LEAP THERAPEUTICS, INC.

LPTX Quotes by TradingView
  • Ticker LPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,021,400
  • Market Cap $275M
  • Description
  • Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...
More about LPTX
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email